BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ribatti D, Solimando AG, Pezzella F. The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer. Cancers (Basel) 2021;13:3433. [PMID: 34298648 DOI: 10.3390/cancers13143433] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Körfer J, Lordick F, Hacker UT. Molecular Targets for Gastric Cancer Treatment and Future Perspectives from a Clinical and Translational Point of View. Cancers (Basel) 2021;13:5216. [PMID: 34680363 DOI: 10.3390/cancers13205216] [Reference Citation Analysis]
2 Gonçalves DA, Jasiulionis MG, Melo FHM. The Role of the BH4 Cofactor in Nitric Oxide Synthase Activity and Cancer Progression: Two Sides of the Same Coin. Int J Mol Sci 2021;22:9546. [PMID: 34502450 DOI: 10.3390/ijms22179546] [Reference Citation Analysis]
3 Ayuso-Íñigo B, Méndez-García L, Pericacho M, Muñoz-Félix JM. The Dual Effect of the BMP9-ALK1 Pathway in Blood Vessels: An Opportunity for Cancer Therapy Improvement? Cancers (Basel) 2021;13:5412. [PMID: 34771575 DOI: 10.3390/cancers13215412] [Reference Citation Analysis]